LB Pharmaceuticals (LBRX) Stock Forecast & Price Target

LBRX Forecast - Frequently Asked Questions

What is LB Pharmaceuticals' forecast for 2026?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for LB Pharmaceuticals is $37.20, with a high forecast of $45.00 and a low forecast of $31.00.

Should I buy or sell LB Pharmaceuticals stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LB Pharmaceuticals in the last year. There is currently 1 sell rating, 1 hold rating, 4 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LBRX shares.

Does LB Pharmaceuticals's stock price have much upside?

According to analysts, LB Pharmaceuticals's stock has a predicted upside of 16.25% based on their 12-month stock forecasts.

Has LB Pharmaceuticals been upgraded by Wall Street analysts recently?

Over the previous 90 days, LB Pharmaceuticals's stock had 1 upgrade by analysts.

What analysts cover LB Pharmaceuticals?

LB Pharmaceuticals has been rated by research analysts at Craig Hallum, HC Wainwright, and Stifel Nicolaus in the past 90 days.

Do Wall Street analysts like LB Pharmaceuticals more than its competitors?

Analysts like LB Pharmaceuticals more than other "manufacturing" companies. The consensus rating for LB Pharmaceuticals is Moderate Buy while the average consensus rating for "manufacturing" companies is Hold. Learn more on how LBRX compares to other companies.